Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Novelion Therapeutics Inc. (NVLN)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 1,655,000 $3,409 +1% 1.1%
2.
Broadfin Capital

Kevin Kotler

5,269,831 $10,856 +19% 0.97%
3.
Greenwood Investments

Steve Tannenbaum

122,000 $251 -72% 0.75%
4. 3,000,000 $6,120 0.68%
5.
Dorset Management

David M. Knott

545,926 $1,125 0.58%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaning Holdings Date Form 4
$1.55 14,928 Large Shareholder 5,778,496 2016-09-15 Filing
$1.55 56,864 Large Shareholder 5,763,568 2016-09-14 Filing
$1.54 61,704 Large Shareholder 5,706,704 2016-09-13 Filing
$2.49 400 Director 461,478 2015-12-29 Filing
$2.50 18,000 Director 461,078 2015-12-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.47 8,865,036 Large Shareholder 0 2015-06-16 Filing
$3.47 7,563,053 Large Shareholder 0 2015-06-16 Filing
$5.80 1,000,000 Large Shareholder 6,447,626 2014-07-11 Filing
$4.39 288,890 Large Shareholder 7,563,053 2013-07-01 Filing
$7.96 100 Officer 1,200 2013-05-14 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 5,778,496 $11,904 9.7%
2. 2,157,200 $4,444 7.03%
3. 1,592,993 $3,282 2.26%
4. 3,313,715 $6,826 0.69%
5. 1,402,302 $2,889 0.32%